Literature DB >> 18306976

A novel TSHR gene mutation (Ile691Phe) in a Chinese family causing autosomal dominant non-autoimmune hyperthyroidism.

Zheng Liu1,2,3, Yuanming Sun2, Qingming Dong3, Mingliang He3, Christopher H K Cheng1, Feiyue Fan4.   

Abstract

Familial non-autoimmune hyperthyroidism is a rare autosomal dominant genetic disease resulting from activating mutations in the thyroid-stimulating hormone receptor (TSHR) gene. In this work a Chinese family with autosomal dominant non-autoimmune hyperthyroidism across four generations was collected. The strongest evidence for linkage in this study occurred on chromosome 14q24.2-31.3. By mutation scan of the TSHR gene located within the region of interest, a heterozygote substitution (A > T) at position 2071 of the TSHR was found, changing isoleucine 691 to phenylalanine. Our study identified the first germline mutation in the intracellular C-terminal domain of TSHR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306976     DOI: 10.1007/s10038-008-0257-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  11 in total

1.  Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.

Authors:  Susanne Neumann; Maren Claus; Ralf Paschke
Journal:  Eur J Endocrinol       Date:  2005-04       Impact factor: 6.664

Review 2.  Somatic and germline mutations of the TSH receptor gene in thyroid diseases.

Authors:  J Van Sande; J Parma; M Tonacchera; S Swillens; J Dumont; G Vassart
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

Review 3.  The human thyrotropin receptor is highly mutable: a review of gain-of-function mutations.

Authors:  N R Farid; V Kascur; C Balazs
Journal:  Eur J Endocrinol       Date:  2000-07       Impact factor: 6.664

4.  A locus for autosomal dominant accessory auricular anomaly maps to 14q11.2-q12.

Authors:  Yongjia Yang; Jihong Guo; Zheng Liu; Siyuan Tang; Ningdong Li; Mengrong Yang; Qiong Pang; Feiyue Fan; Juan Bu; Song Tao Yuan; Xiangjun Xiao; Yuxiang Chen; Kanxing Zhao
Journal:  Hum Genet       Date:  2006-06-15       Impact factor: 4.132

5.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.

Authors:  J Parma; L Duprez; J Van Sande; P Cochaux; C Gervy; J Mockel; J Dumont; G Vassart
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

Review 6.  Genetics of congenital hypothyroidism.

Authors:  S M Park; V K K Chatterjee
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

7.  Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG.

Authors:  Guillaume Smits; Cédric Govaerts; Isabelle Nubourgh; Leonardo Pardo; Gilbert Vassart; Sabine Costagliola
Journal:  Mol Endocrinol       Date:  2002-04

8.  A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.

Authors:  Helmut Grasberger; Jacqueline Van Sande; Ahmad Hag-Dahood Mahameed; Yardena Tenenbaum-Rakover; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

9.  Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.

Authors:  L Duprez; J Parma; J Van Sande; A Allgeier; J Leclère; C Schvartz; M J Delisle; M Decoulx; J Orgiazzi; J Dumont
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

10.  Microsatellites and PCR primers for genetic studies and genomic sequencing of the human TSH receptor gene.

Authors:  N de Roux; M Misrahi; N Chatelain; B Gross; E Milgrom
Journal:  Mol Cell Endocrinol       Date:  1996-03-25       Impact factor: 4.102

View more
  6 in total

Review 1.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

2.  2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations.

Authors:  R Paschke; M Niedziela; B Vaidya; L Persani; B Rapoport; J Leclere
Journal:  Eur Thyroid J       Date:  2012-10-04

3.  Detection of combined genomic variants in a Jordanian family with familial non-autoimmune hyperthyroidism.

Authors:  Said I Ismail; Ismail S Mahmoud; Mahmoud Al-Ardah; Amid Abdelnour; Nidal A Younes
Journal:  J Genet       Date:  2009-08       Impact factor: 1.166

4.  Lack of consistent association of thyrotropin receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism.

Authors:  J Lueblinghoff; S Mueller; J Sontheimer; R Paschke
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

5.  Constitutive activation of the thyroid-stimulating hormone receptor (TSHR) by mutating Ile691 in the cytoplasmic tail segment.

Authors:  Zheng Liu; Feiyue Fan; Xiangjun Xiao; Yuanming Sun
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

6.  Central TSH Dysregulation in a Patient with Familial Non-Autoimmune Autosomal Dominant Hyperthyroidism Due to a Novel Thyroid-Stimulating Hormone Receptor Disease-Causing Variant.

Authors:  Jasna Suput Omladic; Maja Pajek; Urh Groselj; Katarina Trebusak Podkrajsek; Magdalena Avbelj Stefanija; Mojca Zerjav Tansek; Primoz Kotnik; Tadej Battelino; Darja Smigoc Schweiger
Journal:  Medicina (Kaunas)       Date:  2021-02-25       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.